{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:06:04Z","timestamp":1784030764638,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejpn.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:19:38Z","timestamp":1782109178000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peroxisomal disorders - incidences in Sweden"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-0983","authenticated-orcid":false,"given":"Maria","family":"Blomqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Naess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Eric","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"von D\u00f6beln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1152\/physrev.00051.2021","article-title":"The physiological functions of human peroxisomes","volume":"103","author":"Wanders","year":"2023","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.ejpn.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","article-title":"Human disorders of peroxisome metabolism and biogenesis","volume":"1863","author":"Waterham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ejpn.2026.06.006_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121891","article-title":"Characterization of severity in Zellweger spectrum disorder by clinical findings: a scoping review, meta-analysis and medical chart review","volume":"11","author":"Bose","year":"2022","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.ejpn.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1093\/hmg\/ddv305","article-title":"A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform","volume":"24","author":"Bar\u00f8y","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int. J. Dev. Neurosci."},{"issue":"26","key":"10.1016\/j.ejpn.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2026.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107734","article-title":"Newborn screening for adrenoleukodystrophy: international experiences and challenges","volume":"140","author":"Videb\u00e6k","year":"2023","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.ejpn.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awy299","article-title":"Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness","volume":"142","author":"Huffnagel","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejpn.2026.06.006_bib9","series-title":"GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle Copyright \u00a9 1993-2024, University of Washington, Seattle","article-title":"Adult Refsum Disease","author":"Waterham","year":"1993"},{"issue":"4","key":"10.1016\/j.ejpn.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2008-1071495","article-title":"Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy","volume":"21","author":"Kyllerman","year":"1990","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.ejpn.2026.06.006_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/cen.12159","article-title":"Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease","volume":"79","author":"Horn","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.ejpn.2026.06.006_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0387-7604(03)00033-0","article-title":"Gas chromatography\/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders","volume":"25","author":"Takemoto","year":"2003","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13256-017-1365-5","article-title":"Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report","volume":"11","author":"Blomqvist","year":"2017","journal-title":"J. Med. Case Rep."},{"issue":"2","key":"10.1016\/j.ejpn.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-3476(87)80084-7","article-title":"Diagnosis of Zellweger syndrome by analysis of bile acids and plasmalogens in stored dried blood collected at neonatal screening","volume":"111","author":"Gustafsson","year":"1987","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.ejpn.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/clinchem\/47.12.2124","article-title":"Determination of L-pipecolic acid in plasma using chiral liquid chromatography-electrospray tandem mass spectrometry","volume":"47","author":"Rashed","year":"2001","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13073-021-00855-5","article-title":"Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients","volume":"13","author":"Stranneheim","year":"2021","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.ejpn.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ejpn.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MED.0000000000000782","article-title":"An update on the diagnosis and treatment of adrenoleukodystrophy","volume":"30","author":"Gujral","year":"2023","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"4","key":"10.1016\/j.ejpn.2026.06.006_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109265","article-title":"Nationwide Study of the epidemiology and clinical features of X-Linked adrenoleukodystrophy in Denmark","volume":"146","author":"Videb\u00e6k","year":"2025","journal-title":"Mol. Genet. Metabol."},{"issue":"7","key":"10.1016\/j.ejpn.2026.06.006_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/genes15070838","article-title":"Newborn screening for X-Linked adrenoleukodystrophy (X-ALD): Biochemical, molecular, and clinical characteristics of other genetic conditions","volume":"15","author":"Mares Beltran","year":"2024","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.ejpn.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41436-019-0468-3","article-title":"Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools","volume":"21","author":"Vasiljevic","year":"2019","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2026.06.006_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13023-021-01889-z","article-title":"Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata","volume":"16","author":"Luisman","year":"2021","journal-title":"Orphanet J. Rare Dis."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:35:30Z","timestamp":1784028930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379826000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"alternative-id":["S1090379826000565"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.06.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisomal disorders - incidences in Sweden","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}